EGFR protein expression and gene amplification in squamous intraepithelial lesions and squamous cell carcinomas of the cervix

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 2, 2014, Pages 742-750

  Li, Qing ^a,b   Tang, Yongfeng ^b   Cheng, Xue ^b   Ji, Jie ^b   Zhang, Jingmin ^b   Zhou, Xiaojun ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cervix neoplasms; EGFR; FISH; Gene amplification; Gene copy number; Protein expression

Indexed keywords

EID: 84894046747     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Pectasides D, Kamposioras K, Papaxoinis G, Pectasides E. Chemotherapy for recurrent cervical cancer. Cancer Treat Rev 2008; 34: 603-613.
2. Hirsch FR, Varella-Garcia M, Bunn PA Jr, Di Maria MV, Veve R, Bremmes RM, Barón AE, Zeng C, Franklin WA. Epidermal Growth Factor Receptor in Non-Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis. J Clin Oncol 2003; 21: 3798-3807.
3. Mian C, Bancher D, Kohlberger P, Kainz C, Haitel A, Czerwenka K, Stani J, Breitenecker G, Wiener H. Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, X and relationship to HPV infection. Gynecol Oncol 1999; 75: 41-46.
4. Kirchoff M, Rose H, Petersen BL, Maahr J, Gerdes T, Philip J, Lundsteen C. Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lesions. Cancer Genet Cytogenet 2001; 129: 47-51.
5. Sampson JH, Crotty LE, Lee S, Archer GE, Ashley DM, Wikstrand CJ, Hale LP, Small C, Dranoff G, Friedman AH, Friedman HS, Bigner DD. Unarmed, tumor specific moncolomal antibody effectively treats brain tumors. Proc Natl Acad Sci U S A 2000; 97: 7503-7508.
6. Mayer A, Takimoto M, Fritz E, Schellander G, Kofler K, Ludwig H. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 1993; 71: 2454-2460.
7. Atmaca A, Werner D, Pauligk C, Steinmetz K, Wirtz R, Altmannsberger HM, Jäger E, Al-Batran SE. The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer. BMC Cancer 2012; 12: 524.
8. Zhang YJ, Gallis B, Taya M, Wang S, Ho RJ, Sasaki T. pH-Responsive Artemisinin Derivatives and Lipid Nanoparticle Formulations Inhibit Growth of Breast Cancer Cells In Vitro and Induce Down-Regulation of HER Family Members. PLoS One 2013; 8: e59086.
9. Mclendon RE, Wikstrand CJ, Matthews MR, Al-Baradei R, Bigner SH, Bigner DD. Glioma associated antigen expression in oligodendroglial neoplasms. Tenascin and epidermal growth factor receptor. J Histochem 2000; 48: 1103-1110.
10. Tomov S, Popovska S, Veselinova T, Gorchev G, Velkova A. Immunohistochemical analysis of epidermal growth factor receptors expression in malignant ovarian tumors Akush Ginekol. Akush Ginekol (Sofiia) 2005; 44: 42-47.
11. Tangjitgamol S, Ramirez PT, Sun CC, See HT, Jhingran A, Kavanagh JJ, Deavers MT. Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study. Int J Gynecol Cancer 2005; 15: 646-656.
12. Longatto-Filho A, Pinheiro C, Martinho O, Moreira MA, Ribeiro LF, Queiroz GS, Schmitt FC, Baltazar F, Reis RM. Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma. BMC Cancer 2009; 9: 212.
13. Soonthornthum T, Arias-Pulido H, Joste N, Lomo L, Muller C, Rutledge T, Verschraegen C. Epidermal growth factor receptor as a biomarker for cervical cancer. Ann Oncol 2011; 22: 2166-2178.
14. Marzano R, Corrado G, Merola R, Sbiroli C, Guadagni F, Vizza E, Del Nonno F, Carosi M, Galati MM, Sperduti I, Cianciulli AM. Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression. Eur J Cancer 2004 Jul; 40: 1624-9.
15. Buerger H, Gebhardt F, Schmidt H, Beckmann A, Hutmacher K, Simon R, Lelle R, Boecker W, Brandt B. Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression. Cancer Res 2000; 60: 854-857.
16. Utsugi T. New challenges and inspired answers for anticancer drug discovery and development. Jpn J Clin Oncol 2013; 43: 945-953.
17. Goncalves A, Fabbro M, Lhomme C, Gladieff L, Extra JM, Floquet A, Chaigneau L, Carrasco AT, Viens P. A phase II trial to evaluate gefitinib as second-or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer. Gynecol Oncol 2008; 108: 42-46.